The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1245
October 9, 2006
View Complete Issue         Table of Contents 2019 
A Progestin Implant (Implanon) for Long-Term Contraception
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A Progestin Implant (Implanon) for Long-Term Contraception
October 9, 2006 (Issue: 1245)
Implanon (Organon), an implantable contraceptive containing the progestin etonogestrel, has been approved by the FDA. Two other implantable contraceptives, Norplant and Jadelle, which both contain levonorgestrel, are FDA-approved but not marketed in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: A Progestin Implant (Implanon) for Long-Term Contraception
Article code: 1245b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.